TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis

Clinical Chemistry

Volumn 45, Issue 3, 1999, Pages 400-405

  Franciotta, Diego ^a   Martino, Gianvito ^b   Brambilla, Elena ^b   Zardini, Elisabetta ^a   Locatelli, Vera ^a   Bergami, Alessandra ^b   Tinelli, Carmine ^a   Desina, Gaetano ^c   Cosi, Vittorio ^d  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; CHOLINERGIC RECEPTOR ANTIBODY; IODINE 125;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISORDER; SCREENING TEST;

EID: 0032911233     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.3.400     Document Type: Article

References (17)

1. 1. Patrick J, Lindstrom JM. Autoimmune response to acetylcholine receptor. Science 1973;180:871-2.
2. 2. Kawanami S, Tsuji R, Oda K. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Ann Neurol 1984;15:195-200.
3. 3. Hinman CL, Kellogg CM, Ernstoff RM, Rauch HC, Hudson RA. Immunoenzymometric assay and radioimmunoassay measure different populations of antibody against human acetylcholine receptor. Clin Chem 1985;31:835-40.
4. 4. Dwyer DS, Bradley RJ, Urquhart CK, Kearney JF. An enzyme-linked immunosorbent assay for measuring antibodies against muscle acetylcholine receptor. J Immunol Methods 1983;57:111-9.
5. 5. Syapin PJ, Salvaterra PM, Engelhardt JK. Neuronal-like features of TE671 cells: presence of a functional nicotinic cholinergic receptor. Brain Res 1982;231:365-77.
6. 6. Walker R, Vincent A, Newsom-Davis J. Immunological and pharmacological heterogeneity of α-bungarotoxin binding sites extracted from TE671 cells. J Neuroimmunol 1988;19:149-57.
7. 7. Voltz R, Hohlfeld R, Fateh-Moghadam A, Witt TN, Wick M, Reimers C, et al. Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671. Neurology 1991;41:1836-8.
8. 8. Kennel PF, Vilquin JT, Braun S, Fonteneau P, Warter JM, Poindron P. Myasthenia gravis: comparative autoantibody assays using human muscle, TE671, and glucocorticoid-treated TE671 cells as sources of antigen. Clin Immunol Immunopathol 1995;74:293-6.
9. 9. Somnier FE. Anti-acetylcholine receptor (Ach-R) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen. J Neuroimmunol 1994;51:63-8.
10. 10. Martino G, Twaddle G, Brambilla E, Grimaldi LME. Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line. Acta Neurol Scand 1994;89:18-22.
11. 11. Osserman KE, Genkins G. Studies in myasthenia gravis: review of twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
12. 12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
13. 13. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-62.
14. 14. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-52.
15. 15. Somnier FE. Clinical implementation of anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 1993;56:496-504.
16. 2+ influx. Two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells. J Biol Chem 1992;267:2164-72.
17. 17. De Mendonca Neto EC, Kumar A, Shadik NA, Michon AM, Matsudaira P, Eaton, et al. Antibodies to T-and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus. J Clin Investig 1992;90:37-42.